Leonard Dunn

446 total citations
9 papers, 185 citations indexed

About

Leonard Dunn is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Leonard Dunn has authored 9 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 1 paper in Molecular Biology. Recurrent topics in Leonard Dunn's work include Asthma and respiratory diseases (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Leonard Dunn is often cited by papers focused on Asthma and respiratory diseases (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Leonard Dunn collaborates with scholars based in United States, Germany and United Kingdom. Leonard Dunn's co-authors include Benjamin Krämer, Cheryl Lassen, Roland Buhl, Michael V. Henley, Carlos Disdier, Kimberly Denis-Mize, Harold S. Nelson, Nicholas J. Gross, Jason Harris and Edward Kerwin and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Respiratory Medicine.

In The Last Decade

Leonard Dunn

8 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leonard Dunn United States	6	181	149	6	4	4	9	185
Kenneth Chinsky United States	4	140 0.8×	111 0.7×	5 0.8×	1 0.3×	2 0.5×	5	148
Xavier Nuñez Switzerland	4	82 0.5×	62 0.4×	2 0.3×	1 0.3×	2 0.5×	6	84
Li An China	7	72 0.4×	47 0.3×	5 0.8×	15 3.8×	6 1.5×	11	97
B Al-Sheklly United Kingdom	4	83 0.5×	70 0.5×		4 1.0×		13	85
E Valovirta Denmark	6	47 0.3×	127 0.9×	2 0.3×	1 0.3×		7	145
Natalya Makulova Italy	1	68 0.4×	68 0.5×		8 2.0×		2	78
Margret Jandl Germany	4	37 0.2×	49 0.3×	1 0.2×	7 1.8×	2 0.5×	12	66
Anna Whalen-Browne Canada	2	46 0.3×	51 0.3×		3 0.8×		3	57
I. Baiardini Italy	3	31 0.2×	72 0.5×	2 0.3×	1 0.3×		3	77
Andy Lam Canada	2	48 0.3×	34 0.2×		3 0.8×	1 0.3×	2	62

Countries citing papers authored by Leonard Dunn

Since Specialization

Citations

This map shows the geographic impact of Leonard Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Dunn more than expected).

Fields of papers citing papers by Leonard Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Dunn. The network helps show where Leonard Dunn may publish in the future.

Co-authorship network of co-authors of Leonard Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Dunn. A scholar is included among the top collaborators of Leonard Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Dunn. Leonard Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Chapman, Chris, et al.. (2022). A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult Subjects. Drug Research. 73(2). 95–104.

Dunn, Leonard, Edward Kerwin, Kiernan DeAngelis, et al.. (2019). Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD. Pulmonary Pharmacology & Therapeutics. 60. 101873–101873. 6 indexed citations

Fogarty, Charles, Leonard Dunn, Earl St. Rose, et al.. (2012). Pearl Therapeutics' Formoterol Fumarate MDI (FF-MDI, PT005) Demonstrates Pharmacokinetic Bioequivalence To Foradil® Aerolizer® In A Randomized, Double-Blind, Single Dose, Six-Treatment, Placebo-Controlled, Crossover Phase 2b Study In Patients With Moderate To Severe Chronic Obstructive Pulmonary Disease. A2929–A2929. 1 indexed citations

Korn, Stephanie, Oliver Kornmann, Leonard Dunn, et al.. (2011). Efficacy of indacaterol is maintained in patients with moderate or less and severe or worse COPD. European Respiratory Journal. 38(Suppl 55). p860–p860. 2 indexed citations

Buhl, Roland, Leonard Dunn, Carlos Disdier, et al.. (2011). Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD. European Respiratory Journal. 38(4). 797–803. 101 indexed citations

Reisner, Colin, Charles Fogarty, Selwyn Spangenthal, et al.. (2011). Novel Combination Of Glycopyrrolate And Formoterol MDI (GFF-MDI) Provides Superior Bronchodilation Compared To Its Components Administered Alone, Tiotropium DPI, And Formoterol DPI In A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study In Patients With COPD. A6435–A6435. 17 indexed citations

Dunn, Leonard, Roland Buhl, Cheryl Lassen, Michelle Henley, & Benjamin Krämer. (2010). Blinded 12-Week Comparison of Once-daily Indacaterol and Tiotropium in COPD. CHEST Journal. 138(4). 719A–719A. 7 indexed citations

Gross, Nicholas J., et al.. (2007). Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. Respiratory Medicine. 102(2). 189–197. 39 indexed citations

Dunn, Leonard, et al.. (1980). Desquamative Interstitial Pneumonitis. CHEST Journal. 77(4). 552–554. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact